Login
$WGS
$50.50 -$0.52 (1.02%) After hours

$WGS SEC Filings

Filed On Filing
13 Nov 2026 SCHEDULE 13G/A
09 Nov 2026 10-Q
09 Nov 2026 8-K: Results of Operations and Financial Condition

GAITHERSBURG, Md., November 9, 2026 — GeneDx Holdings Corp. (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today reported its financial results for the third quarter of 2026.

06 Nov 2026 SCHEDULE 13G
18 Sep 2026 Form 4: Stueland Katherine, Director

Received 18,750 shares by exercise or conversion · Sold 10,501 shares ($1.03M)

18 Sep 2026 Form 4: Feeley Kevin, CHIEF FINANCIAL OFFICER

Received 7,197 shares by exercise or conversion · Sold 3,728 shares ($364K)

18 Sep 2026 Form 4: Fuchs Thomas, Director

Received 1,146 shares by exercise or conversion

11 Sep 2026 Form 4: Stueland Katherine, Director

Received 6,547 shares by exercise or conversion · Sold 3,692 shares ($311K)

11 Sep 2026 Form 4: Feeley Kevin, CHIEF FINANCIAL OFFICER

Received 2,462 shares by exercise or conversion · Sold 1,285 shares ($108K)

03 Sep 2026 Form 4: Feeley Kevin, CHIEF FINANCIAL OFFICER

Received 717 shares by exercise or conversion · Sold 372 shares ($31.2K)

01 Sep 2026 144
01 Sep 2026 144
11 Aug 2026 SCHEDULE 13G
07 Aug 2026 SCHEDULE 13G/A
03 Aug 2026 10-Q
03 Aug 2026 8-K: Results of Operations and Financial Condition

GAITHERSBURG, Md., August 3, 2026 — GeneDx Holdings Corp. (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today reported its financial results for the second quarter of 2026.

28 Jul 2026 SCHEDULE 13G
21 Jul 2026 25-NSE
01 Jul 2026 Form 4: Gardner Mark A, President

Granted 35,441 Restricted Stock Unit

23 Jun 2026 Form 4: Ryan Jason, Director

Received 3,576 shares by exercise or conversion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support